Pershing Square Sohn Cancer Research Alliance Initiative
Supports early-career scientists in the U.S. conducting innovative, high-risk cancer research with funding and professional development through the Pershing Square Sohn Cancer Research Alliance Initiative.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total ($250,000/year for 3 years); minimum 6 awards annually
Summary: Supports early-career scientists pursuing innovative, high-risk, high-reward cancer research in the United States.
Key Information: Eligibility now open to all U.S. institutions; only two lifetime applications per investigator.
Description
The Pershing Square Sohn Cancer Research Alliance Initiative provides substantial funding and professional development opportunities to early-career scientists conducting cutting-edge cancer research in the United States. Designed to empower researchers at a formative stage, the program emphasizes bold, high-risk, high-reward projects that have transformative potential for the understanding, diagnosis, prevention, or treatment of cancer. Awardees join a vibrant network and gain access to industry leaders, networking events, and opportunities for collaboration and visibility.
